Notice on share buyback status. Acquisition period is from June 1, 2026 to December 23, 2026; purpose is market purchases; total shares acquired: 0 shares; acquisition amount: unknown; method: market purchases under a discretionary trading system on the Tokyo Stock Exchange.<\/p>\n","protected":false},"comment_status":"open","ping_status":"closed","template":"","meta":{"Ticker":"","DATE":"","longName":"","company_name_ja":"","fullTimeEmployees":0,"address":"","phone":"","website":"","industry":"","sector":"","regularMarketPrice":0,"financialCurrency":"","marketCap":0,"fiftyTwoWeekLow":0,"fiftyTwoWeekHigh":0,"epsTrailingTwelveMonths":0,"epsForward":0,"bookValue":0,"totalRevenue":0,"OperatingIncome":0,"operatingMargins":0,"NetIncome":0,"profitMargins":0,"ebitda":0,"trailingPE":0,"forwardPE":0,"priceToBook":0,"returnOnEquity":0,"recommendationMean":0,"recommendationKey":"","targetMeanPrice":0,"numberOfAnalystOpinions":0,"analyst_earnings_data":"","dividendRate":0,"dividendYield":0,"payoutRatio":0,"totalEsg":0,"environmentScore":0,"socialScore":0,"governanceScore":0,"title":"","providerPublishTime":"","link":"","longBusinessSummary":"","longBusinessSummary_ja":"","quarterly_revenue":0,"quarterly_net_income":0,"quarterly_operating_profit":0,"enterprise_value":0,"company_officer_1_name":"","company_officer_1_title":"","company_officer_2_name":"","company_officer_2_title":"","company_officer_3_name":"","company_officer_3_title":"","company_officer_4_name":"","company_officer_4_title":"","company_officer_5_name":"","company_officer_5_title":"","company_officers_update_time":"","get_dividend_history_year1":0,"get_dividend_history_year2":0,"get_dividend_history_year3":0,"get_dividend_history_year4":0,"get_dividend_history_year5":0,"get_dividend_history_year6":0,"get_dividend_history_year7":0,"get_dividend_history_year8":0,"get_dividend_history_year9":0,"get_dividend_history_year10":0,"site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"jir_stock_code":"9902","jir_company_name":"Nisshin Pharmaceutical Co., Ltd.","jir_importance":"\u2605\u2605\u2605\u2605\u2606","jir_publication_date":"2026-07-01","jir_source_link":"https:\/\/japanir.jp\/wp-content\/uploads\/2026\/07\/9902-20260701-01.pdf","jir_short_summary":"Notice on share buyback status. Acquisition period is from June 1, 2026 to December 23, 2026; purpose is market purchases; total shares acquired: 0 shares; acquisition amount: unknown; method: market purchases under a discretionary trading system on the Tokyo Stock Exchange.","jir_summary":"### Section Heading\nThis notice discloses Nisshin Pharmaceutical's policy and status of share buybacks. The method is market purchases, and the acquisition period is from June 1, 2026 to December 23, 2026. Specific figures for total shares acquired and acquisition amount are not disclosed in the PDF, and further disclosure is required to monitor.\n\n### Section 2 Heading\nThis matter may be positioned as part of capital policy and a component of shareholder returns, but at this time the specific dilutive effects and impact on capital structure are unknown. further progress and disclosure are needed.","jir_financial_highlights":"Total number of shares acquired: 0 shares (Unknown)\nTotal acquisition amount: Unknown (Unknown)\nAcquisition period: June 1, 2026 to December 23, 2026","jir_category":"","jir_hashtags":"#NisshinPharmaceutical, #CapitalPolicy, #JapanStocks","jir_key_figures":"Acquisition period: June 1, 2026 to December 23, 2026\nTotal shares acquired: 0 shares (Unknown)\nMethod: Market purchases (discretionary trading system)","jir_meta_title":"Nisshin Pharmaceutical - Notice of Share Buyback Status | July 2026","jir_meta_description":"Notice on Nisshin Pharmaceutical's share buyback status. Acquisition period is June 1 to December 23, 2026; method is market purchases. Total shares acquired and acquisition amount are currently unknown, with attention on future disclosures.","jir_og_title":"Nisshin Pharmaceutical - Notice of Share Buyback Status","jir_og_description":"Nisshin Pharmaceutical discloses share buyback status. Period and method are market purchases, but total shares and acquisition amount are unknown.","jir_og_image_url":"\/assets\/og\/company-share_buyback.jpg","jir_chart_data_collection":"[]","ir_related_company":16896,"ir_release_date":"","ir_type":"","ir_is_new":false,"ir_document_url":"","jir_ir_type":"share_buyback","footnotes":""},"sector":[],"importance":[],"class_list":["post-73881","ir_release","type-ir_release","status-publish","hentry"],"yoast_head":"\n